Turkey's Abdi Ibrahim in talks for minority-stake sale; AZ's Nexium as effective as surgery in reflux;

@FiercePharma: Forest shareholder demands CEO's resignation. Report | Follow @FiercePharma

> Abdi Ibrahim Ilac Sanayi & Ticaret, Turkey's biggest generic drugmaker, said it's in talks with foreign companies on the possible sale of a minority stake. Story

> AstraZeneca's Nexium is as effective as surgery for patients with gastroesophageal reflux disease, according to a five-year study published in the Journal of the American Medical Association. News

> Sanofi's Genzyme unit sued Allergan for patent royalties on sales of wrinkle filler Juvederm. Story

> Swiss pharmaceuticals company Roche (ROG.VX) said that new drug data show that its personalized health care approach is working for patients suffering from skin and lung cancer. Report

> Roche's Genentech unit sued Apotex for planning to sell a generic version of Valcyte, which treats a virus that afflicts transplant patients and people with AIDS, before its patent expires. Item

> Pfizer's Canadian chief said that country must adjust the rules around intellectual property or risk losing ground in the competitive world of biotech and pharmaceutical research. Article

Biotech News

@FierceBiotech: Biotechs pick up slack in antibiotics development. Article | Follow @FierceBiotech

@JohnCFierce: IMS expects US drug sales to grow from 0 to 3% per year to 2015, less than half the rate we've been seeing. Story | Follow @JohnCFierce

> Deal or no deal? Takeda scuttles report on imminent $13B pact for Nycomed. Report

> Roche cancer programs angle for a starring role at ASCO. Story

> CRO consolidation continues as inVentiv scoops up PharmaNet. Item

Drug Delivery News

> Consultant: Gene and cell therapy almost ready for prime time. Item

> 'Magnetofection' delivers DNA in experimental malaria vaccine. Article

> Microdosing project to help develop drugs for infants. Story

> More than one way to produce particles for inhaled drug delivery. Report

> Analyst: Fluzone Intradermal 'delivers the goods' in a patient-friendly system. Story

> 'Nanobot?" Maybe not, but cool, anyway. Item

Medical Device News

> Shire buys Advanced BioHealing for $750M. News

> Stryker to cut 142 jobs in Ireland. Report

> Medtronic's decision to end GPO contracts could aid rivals. Story

> Thulin tapped as 3M COO. Article

> Medtronic's CoreValve shows sustained quality of life improvements. Item

And Finally... A recent outbreak of mumps in Canada underscores the importance of getting the recommended two doses of measles-mumps-rubella (MMR) vaccine and not just one, according to a study. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.